stockrowINVO Fertility, Inc
IVFINVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- +100.1%
- Free cash flow
- +35.1%
- Total debt
- −50.7%
Quarter to June 2026, against a year earlier
Follow IVF
Alert me
INVO Fertility, Inc (IVF) Return on invested capital
INVO Fertility, Inc's return on invested capital over the twelve months to 30 June 2026 was −27.9%, up 48.9 percentage points from fiscal 2025 (−76.8%). Over the past ten years it has ranged from −1,102.7% (fiscal 2022) to 0.00% (fiscal 2020); the current reading is higher than 36% of that period. That is below the Medical Devices industry median of −5.22% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −76.8% | (45.14) |
| FY2024 | −31.6% | 189.31 |
| FY2023 | −221.0% | 881.75 |
| FY2022 | −1,102.7% | (1,010.27) |
| FY2021 | −92.4% | (92.43) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | 0.00 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NUWE Nuwellis, Inc. compare | 0.00% |
| AIDX 20/20 Biolabs Inc. compare | 0.00% |
| AMIX Autonomix Medical, Inc. compare | 0.00% |
| BJDX Bluejay Diagnostics, Inc. compare | 0.00% |
| ICCM IceCure Medical Ltd. compare | 0.00% |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | 0.00% |
| IVF INVO Fertility, Inc | −27.9% |
| CODX Co-Diagnostics, Inc. compare | −337.7% |
| VVOS Vivos Therapeutics, Inc. compare | −592.7% |
| Medical Devices industry median | −5.22% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)